Company: AZN
Filing Date: 2025-05-09
Form Type: 6-K
Source: 0001654954-25-005331
Chunk: 5

Company: ASTRAZENECA PLC
Filing Date: 2025-05-09
Form: 6-K
Chunk 5
---
rol . 2012;22:385-389.

4. World Health Organization. International Agency for Research on Cancer. Bladder Fact Sheet. Available at: https://gco.iarc.who.int/media/globocan/factsheets/cancers/30-bladder-fact-sheet.pdf . Accessed May 2025.

5. AstraZeneca PLC. Investor Relations Epidemiology Spreadsheet. Available at: https://www.astrazeneca.com/investor-relations.html . Accessed May 2025.

6. Gontero P, et al. EAU Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and CIS). 2025. Edn. presented at the EAU Annual Congress Madrid 2025. ISBN 978-94-92671-29-5.

#### Matthew Bowden

#### Company Secretary

#### AstraZeneca PLC
<div align='center'>SIGNATURES</div>

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

| AstraZeneca 
 PLC         |

Date: 09 May 2025

| By: /s/           
 Adrian Kemp       |
| Name:             
 Adrian Kemp       |
| Title:            
 Company Secretary |